---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-269652"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:43:50.095710+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# OnKure enters ATM offering agreement with Leerink Partners; up to 3% fee

## Summary
- Sales agreement with Leerink Partners for at-the-market offering of Class A common stock.
- Compensation set at 3.0% of gross proceeds from sales of Placement Shares.
- No minimum offering amount; company may suspend sales at any time.
- Sales commence only after SEC registration statement becomes effective.
- Agreement contains customary representations, warranties, and termination provisions.

## SEC filing metadata
- accession: 0001193125-25-269652
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000119312525269652/0001193125-25-269652-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000119312525269652/okur-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-269652
- JSON: https://secwatch.observer/filing/0001193125-25-269652.json
- Plain text: https://secwatch.observer/filing/0001193125-25-269652.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.